ストックスクリーナーアプリを入手
3.79
1.30%
-0.05
前日終値:
$3.84
開ける：
$3.78
24時間の取引高:
272.92K
Relative Volume:
0.49
時価総額：
$115.57M
収益：
$50.14M
当期純損益:
$-35.38M
株価収益率:
-2.7071
EPS:
-1.4
ネットキャッシュフロー:
$-39.46M
1週間 パフォーマンス:
+1.07%
1か月 パフォーマンス:
-8.01%
6か月 パフォーマンス:
-41.87%
1年 パフォーマンス:
-70.55%
1日の値動き範囲:
$3.72
$3.91
1週間の範囲:
$3.66
$4.09
52週間の値動き範囲:
$3.35
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
RCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.79 | 117.09M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-20 | アップグレード | BTIG Research | Sell → Neutral |
| 2025-08-08 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
Avita Medical (NASDAQ:RCEL) Upgraded at BTIG Research - MarketBeat
Why AVITA Medical Inc. stock is favored by top institutionsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
BTIG Upgrades AVITA Medical (RCEL) - Nasdaq
AVITA Medical Inc (RCEL) Stock News & Articles - 24/7 Wall St.
RCEL Upgraded by BTIG: New Neutral Rating | RCEL Stock News - GuruFocus
BTIG upgrades Avita Medical stock rating to Neutral from Sell By Investing.com - Investing.com Canada
How AVITA Medical Inc. stock performs in high volatility marketsMarket Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Investors to Connect - ACCESS Newswire
Will AVITA Medical Inc. stock benefit from commodity pricesMarket Rally & Growth Oriented Trade Recommendations - newser.com
How to escape a deep drawdown in AVITA Medical Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Historical volatility pattern of AVITA Medical Inc. visualizedMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Q2 2025 AVITA Medical Inc Earnings Call Transcript - GuruFocus
Is AVITA Medical Inc. stock attractive for income investors2025 Price Action Summary & High Return Trade Guides - newser.com
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Why AVITA Medical Inc. stock remains a top recommendationWeekly Trade Report & Community Verified Trade Alerts - newser.com
How AVITA Medical Inc. stock performs during Fed tightening cycles2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
How AVITA Medical Inc. stock performs in weak economyWeekly Market Report & Comprehensive Market Scan Reports - newser.com
How analysts rate AVITA Medical Inc. stock todayJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Connect - ACCESS Newswire
What analysts say about AVITA Medical Inc stockDividend Stability Analysis & Free High Frequency Trading Ideas - earlytimes.in
Brokers Offer Predictions for Avita Medical FY2025 Earnings - MarketBeat
How AVITA Medical Inc. stock performs in interest rate cyclesQuarterly Portfolio Report & AI Powered Market Entry Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Reach Out - ACCESS Newswire
AVITA Medical (RCEL) Q3 2025 Earnings Transcript - AOL.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AVITA Medical, Inc. (RCEL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bragar Eagel & Squire, P.C. Is Investigating Agilon, - GlobeNewswire
AVITA Medical Hits 52-Week Low at $3.37 Amidst Significant Decline - Markets Mojo
AVITA Medical Hits 52-Week Low at $3.35 Amid Significant Decline - Markets Mojo
Using AI based signals to follow AVITA Medical Inc.July 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonTrade Entry Report & Entry Point Strategy Guides - newser.com
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity - MSN
How Volatile Is Azad Engineering Limited Compared to PeersMarket Liquidity Analysis & Access Risk Ratings for Every Stock - earlytimes.in
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
5.84%
大文字化:
|
ボリューム (24 時間):